Open access
67
Views
10
CrossRef citations to date
0
Altmetric
Original Research
Outcomes associated with initiation of tiotropium or fluticasone/salmeterol in patients with chronic obstructive pulmonary disease
Rachel Halpern1 Health Economics and Outcomes Research, OptumInsight, Eden Prairie, MN, USACorrespondence[email protected]
, Christine L Baker2 Global Market Access, Primary Care Business Unit, Pfizer Inc, New York, NY, USA
, Jun Su3 Health Economics and Outcomes Research, Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
, Kimberly B Woodruff2 Global Market Access, Primary Care Business Unit, Pfizer Inc, New York, NY, USA
, Ryne Paulose-Ram2 Global Market Access, Primary Care Business Unit, Pfizer Inc, New York, NY, USA
, Victoria Porter1 Health Economics and Outcomes Research, OptumInsight, Eden Prairie, MN, USA
& Hemal Shah4 Former employee of Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
show all
Pages 375-388
|
Published online: 26 Jul 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.